Clinical trial
A Prospective Observational Study on the Effect of Mepolizumab add-on Therapy on Daily Physical Activity in Patients With Severe Eosinophilic Asthma
NCT03739320 is registered in ClinicalTrials.gov with Sotiria General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Observational Study on the Effect of Mepolizumab add-on Therapy on Daily Physical Activity in Patients With Severe Eosinophilic Asthma
- Lead sponsor
- Sotiria General Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 11, 2017
- Completion date
- December 31, 2019
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
severe eosinophilic asthma